Finance

Lists
NOTA:FRA
Novartis
၁၃၆.၀၀ €
၀.၀၀%
(၀.၀၀) 1D
အောက် ၂၂, GMT+၂ ၀၈:၅၃:၂၁  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NOTA...
Open
၁၃၆.၀၀ €
High
၁၃၆.၀၀ €
Low
၁၃၆.၀၀ €
Mkt. cap
ဋေ ၂.၆၀ သ
Avg. vol.
၂၉.၀၀
Volume
၀.၀၀
52-wk high
၁၄၅.၀၀ €
52-wk low
၁၀၂.၅၀ €
No. of employees
၈ သောင်း
Open
၁၃၆.၀၀ €
High
၁၃၆.၀၀ €
Low
၁၃၆.၀၀ €
Mkt. cap
ဋေ ၂.၆၀ သ
Avg. vol.
၂၉.၀၀
Volume
၀.၀၀
52-wk high
၁၄၅.၀၀ €
52-wk low
၁၀၂.၅၀ €
No. of employees
၈ သောင်း
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၂ နာရီ
Novartis wins EU Cosentyx approval as Novartis stock trades at EUR 137.81
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၃ နာရီ
Novartis stock pre-market at EUR 136.79: medicines company
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၉ နာရီ
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
marketscreener.com
marketscreener.com
·
ပြီးခဲ့သည့် ၂ ရက်
Switzerland's Blue-chip Index Kicks Off Week Downbeat; Novartis Shares Decline
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis
CEOVasant Narasimhan
Employees၇.၅၃ သောင်း
Founded၁၉၉၆ မတ် ၇
Headquartersဘေဆဲလ်, Basel City, ဆွစ်ဇာလန်
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၄၄ ထ
ဋေ ၁.၃၉ ထ
ဋေ ၁.၃၅ ထ
ဋေ ၁.၅၀ ထ
Cost of goods sold
၃၅၃.၅၀ ဋေ
၃၅၄.၂၀ ဋေ
၃၄၃.၈၀ ဋေ
၃၆၇.၈၀ ဋေ
Cost of revenue
၃၅၃.၅၀ ဋေ
၃၅၄.၂၀ ဋေ
၃၄၃.၈၀ ဋေ
၃၆၇.၈၀ ဋေ
Research and development expenses
၂၈၆.၄၀ ဋေ
၂၈၃.၇၀ ဋေ
၂၇၈.၅၀ ဋေ
၂၇၃.၉၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၃၀.၄၀ ဋေ
၃၄၃.၆၀ ဋေ
၃၁၃.၇၀ ဋေ
၃၂၃.၁၀ ဋေ
Operating expense
၆၂၃.၈၀ ဋေ
၆၄၆.၃၀ ဋေ
၅၉၆.၄၀ ဋေ
၆၀၉.၇၀ ဋေ
Total operating expenses
၉၇၇.၃၀ ဋေ
ဋေ ၁.၀၀ ထ
၉၄၀.၂၀ ဋေ
၉၇၇.၅၀ ဋေ
Operating income
၄၅၈.၅၀ ဋေ
၃၈၅.၅၀ ဋေ
၄၁၂.၂၀ ဋေ
၅၁၇.၆၀ ဋေ
Other non operating income
-၇.၀၀ သန်း
-၁၃.၀၀ ကုဋေ
၄.၀၀ သန်း
၁.၉၀ ကုဋေ
EBT including unusual items
၄၁၉.၆၀ ဋေ
၃၂၁.၈၀ ဋေ
၃၈၃.၉၀ ဋေ
၄၂၆.၉၀ ဋေ
EBT excluding unusual items
၄၂၉.၃၀ ဋေ
၃၄၉.၂၀ ဋေ
၃၇၈.၀၀ ဋေ
၄၇၃.၁၀ ဋေ
Income tax expense
၂၆.၆၀ ကုဋေ
၈၁.၄၀ ကုဋေ
၆၈.၃၀ ကုဋေ
၁၀၁.၂၀ ဋေ
Effective tax rate
၆.၃၄%
၂၅.၃၀%
၁၇.၇၉%
၂၃.၇၁%
Other operating expenses
၇.၀၀ ကုဋေ
၁၉.၀၀ ကုဋေ
၄.၂၀ ကုဋေ
၁၂.၇၀ ကုဋေ
Net income
၃၉၂.၈၀ ဋေ
၂၄၀.၉၀ ဋေ
၃၁၅.၆၀ ဋေ
၃၂၆.၄၀ ဋေ
Net profit margin
၂၇.၃၆%
၁၇.၃၈%
၂၃.၃၄%
၂၁.၈၃%
Earnings per share
၂.၂၅
၂.၀၃
၁.၉၉
၂.၄၁
Interest and investment income
-
၃၇.၃၀ ကုဋေ
-
-
Interest expense
-၂၈.၁၀ ကုဋေ
-၃၀.၄၀ ကုဋေ
-၃၄.၃၀ ကုဋေ
-၄၆.၂၀ ကုဋေ
Net interest expenses
-၂၈.၁၀ ကုဋေ
၆.၉၀ ကုဋေ
-၃၄.၃၀ ကုဋေ
-၄၆.၂၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၅၇၇.၅၀ ဋေ
၄၉၅.၆၀ ဋေ
၅၂၃.၈၀ ဋေ
၆၂၉.၉၀ ဋေ
Gain or loss from assets sale
၈.၁၀ ကုဋေ
၈.၀၀ ကုဋေ
-၁၅.၉၀ ကုဋေ
-၂၄.၇၀ ကုဋေ
AI content may include mistakes. Learn more
Google အက်ပ်များ